Viatris (VTRS) News
NASDAQ: VTRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.64+0.20 (+1.15%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
VTRS news summary
We found 6 recent headlines mentioning Viatris (VTRS): 5 in the past week and 5 in the past 30 days, most often from Seeking Alpha, Nasdaq, Investor's Business Daily. For price context, VTRS is up 1.15% at $17.64. The most recent story, "Pacira BioSciences jumps 44% on Viatris acquisition deal", was published by Seeking Alpha on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Viatris headlines
- Pacira BioSciences jumps 44% on Viatris acquisition dealSeeking AlphaPCRX, VTRS
- Why Pacira BioSciences Skyrocketed TodayKey PointsPacira BioSciences is being bought out by Viatrias.NasdaqPCRX, VTRS
- Pacira Biosciences Snags $1.65 Billion Viatris Takeover Deal; Shares FlyViatris pledged Thursday to buy small biotech company Pacira Biosciences for $1.65 billion, sending Pacira stock skyrocketing. The post Pacira Biosciences Snags $1.65 Billion Viatris Takeover Deal;…Investor's Business DailyPCRX, VTRS
- Viatris to buy Pacira BioSciences for $36.50/share in cashSeeking AlphaPCRX, VTRS
- Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain TherapiesAdds Two Marketed, Patent-Protected, High-Margin Medicines in the U.S., EXPAREL® and ZILRETTA®, and Expects to Expand the Products' Reach Across Selected Markets Within Its International…PR NewswirePCRX, VTRS
- After Hours Most Active for Aug 13, 2026 : NXE, SOFI, VTRS, NVDA, INTC, SNAP, AAPL, BAM, MFC, LYB, SMCI, COPThe NASDAQ 100 After Hours Indicator is up 10.14 to 30,094.64. The total After hours volume is currently 118,663,040 shares traded.The following are the most active stocks for the after hours…NasdaqNXE, SOFI, VTRS, NVDA